The Types segment classifies testing methodologies into molecular diagnostics, immunoassays, bioassays, and spectroscopic techniques, each driving distinct cost structures and adoption curves. Molecular diagnostics—primarily PCR, qPCR, and next‑generation sequencing—represent the highest value‑added tier, capturing roughly 40 % of type‑related revenue due to their sensitivity for pathogen DNA/RNA detection and compatibility with high‑throughput screening. Immunoassays, including ELISA and lateral‑flow devices, account for about 30 % of the market; they offer rapid, field‑deployable results at moderate cost, supporting routine surveillance of bacterial and fungal agents. Bioassays, such as growth‑inhibition or toxicity tests, contribute roughly 20 % and remain essential for evaluating biocontrol efficacy and environmental safety. Spectroscopic methods—near‑infrared (NIR), mass spectrometry, and Raman—cover the remaining 10 %, providing non‑destructive residue profiling and metabolomic insights. Collectively, these four type categories account for the entire testing services market, with molecular diagnostics driving the premium segment and spectroscopic methods expanding niche applications such as precision agriculture. Regulatory mandates for pathogen traceability and residue limits have accelerated adoption of molecular and immunoassay platforms, thereby shaping the revenue distribution across the market taxonomy of Agricultural Biologicals Testing.